(S)-(3-Aminopyrrolidin-1-yl)(pyridin-2-yl)methanone dihydrochloride, 1g

1-(TERT-BUTOXYCARBONYL)-4-METHYLPYRROLIDINE-3-CARBOXYLIC ACID, 95.0%, 250mg

(1R,2R)-Cyclohexane-1,2-dicarboxylic Acid, 97%, 100g

TERT-BUTYL 6-NITROINDOLINE-1-CARBOXYLATE, 98.0%, 100mg

Ethyl 6-amino-3,4-dimethoxybenzoate, 97%, 10g

Sodium 2,4-Dimethylbenzenesulfonate Monohydrate>98.0%(T)500g

5,6,11,12-Tetradehydrodibenzo[a,e]cyclooctene, 95%, 100mg

(S)-2-((tert-Butoxycarbonyl)amino)-2-methylpent-4-enoic acid, 98%, 1g

N-[3-(1H-imidazol-1-yl)propyl]-6-methyl-1,3-benzothiazol-2-amine, 95.0%, 250mg

METHYL 4-CHLOROTHIENO[3,2-D]PYRIMIDINE-6-CARBOXYLATE, 95.0%, 250mg

4-Bromo-6-fluoro-7-methyl-1H-indole, 98%, 100mg

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 2 - MWCO 12,000 to 14,000, 45 mm, 1 Piece(s)

2,6-Bis(4-azidobenzylidene)cyclohexanone (wetted with ca. 30% Water) (unit weight on dry weight basis) [Research for Photosensitive Material]>85.0%(HPLC)25g